查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
按產品、類型、應用和方法劃分的全球抗菌藥物敏感性測試市場，最終用戶、地區的未來預測（至 2027 年）
市場調查報告書
商品編碼
1233006

按產品、類型、應用和方法劃分的全球抗菌藥物敏感性測試市場，最終用戶、地區的未來預測（至 2027 年）

Antimicrobial Susceptibility Testing Market by Product (Manual, Automated), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion, Agar Diffusion, Genotyping), End User & Region - Global Forecasts to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 237 Pages | 訂單完成後即時交付

價格
簡介目錄

全球抗菌藥敏試驗市場規模預計將從 2022 年的 36 億美元增長到 2027 年的 47 億美元，在預測期內以 5.5% 的複合年增長率增長。

主要的市場驅動力包括過度使用和濫用抗生素復活耐藥微生物 (AMR)、生物製藥、生物技術以及製藥公司增加使用抗菌藥物敏感性測試。

從產品來看，自動化實驗室儀器將在 2022 年佔據最大份額。自動識別和藥敏系統比傳統的手動系統更昂貴，但具有檢測速度更快的優勢。

按類型分，2022年抗菌感染試驗佔比最大。這是由於存在簡化抗菌藥敏試驗過程的監管指南、該領域的技術進步以及發展中國家和發達國家日益增加的抗菌藥物耐藥性負擔。

按地區劃分，到 2022 年，北美市場將佔據最大份額，達到 35.5%，而亞太地區預計在預測期內也將以 6.7% 的複合年增長率快速增長。

本報告按產品、類型、應用、方法、最終用戶和地區分析了全球抗菌藥敏試驗市場，包括市場的基本結構和最新發展，驅動和製約市場的關鍵因素。市場趨勢展望，市場競爭狀況，主要參與者的概況等。

目錄

第 1 章 簡介

第二章研究方法論

第三章執行摘要

第 4 章重要注意事項

第五章市場概況

  • 介紹
  • 市場動態
    • 促進者
    • 抑製劑
    • 機會
    • 任務
  • 波特五力分析
  • 監管分析
  • 生態系統分析：抗菌藥物敏感性測試市場
  • 價值鏈分析
  • 供應鏈分析
  • 主要會議和活動（2023-2024）
  • 主要利益相關者和採購標準
  • 專利分析

6 抗菌藥物敏感性測試市場，按產品分類

  • 介紹
  • 手動抗菌藥敏試驗產品
    • 藥敏試驗片
    • MIC（最低抑菌濃度）試紙
    • 藥敏試驗板
  • 自動實驗室器具
  • 培養/生長培養基
  • 消耗品

7 抗菌藥物敏感性測試市場，按類型

  • 介紹
  • 抗菌藥敏試驗
  • 抗真菌藥敏試驗
  • 抗寄生蟲藥敏試驗
  • 其他藥敏試驗

8 抗菌藥物敏感性測試市場，按應用

  • 介紹
  • 臨床診斷
  • 藥物發現與開發
  • 流行病學
  • 其他用途

9 抗菌藥物敏感性測試市場，按方法論

  • 介紹
  • 自動測試
  • 圓盤擴散法
  • 瓊脂稀釋法
  • 電子測試方法
  • 基因分型

10 最終用戶的抗菌藥物敏感性測試市場

  • 介紹
  • 醫院/診斷中心
  • 製藥和生物技術公司
  • 研究/教育機構
  • CRO（合同研究組織）

11 抗菌藥物敏感性測試市場，按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東/非洲

第十二章競爭格局

  • 介紹
  • 大公司/有影響力公司的戰略
  • 主要公司的收入份額分析
  • 市場份額分析（2021 年）
  • 前 25 家公司：企業評估矩陣（2021 年）
  • 初創企業/中小企業的業務評估矩陣 (2021)
  • 競爭標桿
  • 競爭情景
    • 產品發佈會
    • 資本交易

第十三章公司簡介

  • 大公司
    • BIOMERIEUX SA
    • BECTON, DICKINSON AND COMPANY
    • THERMO FISHER SCIENTIFIC
    • DANAHER CORPORATION
    • BIO-RAD LABORATORIES, INC.
    • BRUKER
    • ROCHE DIAGNOSTICS
    • MERCK KGAA
    • ACCELERATE DIAGNOSTICS, INC.
    • HIMEDIA LABORATORIES
    • LIOFILCHEM S.R.L.
    • ALIFAX S.R.L.
    • CREATIVE DIAGNOSTICS
    • SYNBIOSIS
    • BIOANALYSE
  • 其他公司
    • ZHUHAI DL BIOTECH CO., LTD.
    • ELITECH GROUP
    • MAST GROUP LTD.
    • CONDALAB
    • GENEFLUIDICS, INC.
    • BIOTRON LTD.
    • INVIVOGEN
    • MP BIOMEDICALS
    • QUANTAMATRIX INC.
    • PML MICROBIOLOGICALS

第十四章附錄

簡介目錄
Product Code: MD 5931

The Antimicrobial Susceptibility Testing market is projected to reach USD 4.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 5.5% during the forecast period. The significant growth of the antimicrobial susceptibility testing market is largely due to the overuse and misuse of antibiotics, which resuresistance microbial resistances (AMR), and the increased use of antimicrobial susceptibility testing by biopharmaceutical, biotechnological, and pharmaceutical companies.

"The automated laboratory instruments to hold the largest share of the market in 2022"

Automated laboratory instruments holds the largest market share in 2022. Automated identification and susceptibility systems are more expensive than manual conventional ones but offer the advantage of quicker findings. Although automated methods are more efficient and of higher quality, some bacteria and antimicrobial agents have specific technological limitations.

"The Antibacterial infections is holding the largest share of the market in 2022"

Based on type, the antimicrobial susceptibility testing market is classified into antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing and other susceptibility testing. The large share of this segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements in this segment, and the rising burden of antibacterial resistance in developing and developed countries.

"The market in North America region is expected to witness the highest growth during the forecast period."

North America accounted for the largest market share-35.4%-in 2022. The increasing R&D to develop novel automated AST systems, rising prevalence of infectious diseases, growing safety concerns, and technological advancements in antimicrobial susceptibility testing products are the key factors supporting market growth in North America

While the APAC is expected to witness significant growth in the coming years. The antimicrobial susceptibility testing market in the APAC region is expected to register a CAGR of 6.7% during the forecast period, primarily due to the growing number of hospitals in Asian countries and favorable government initiatives.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
  • By Designation: C-level-27%, Director-level-18%, and Others-55%
  • By Region: North America-35.3%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%

The prominent player in Antimicrobial susceptibility testing are bioMerieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US)

Research Coverage

This report studies the Antimicrobial susceptibility testing market based on product, design, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microcatheter market.
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the microcatheter market..
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the microcatheter market.
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Insights from primary experts
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 5 TOP-DOWN APPROACH
    • FIGURE 6 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
  • 2.8 IMPACT OF RECESSION ON ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY TYPE, 2022 VS. 2027
    • FIGURE 10 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY END USER, 2022 VS. 2027
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET

4 PREMIUM INSIGHTS

  • 4.1 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET OVERVIEW
    • FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND RISING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
  • 4.2 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 SUSCEPTIBILITY TESTING DISKS SEGMENT TO DOMINATE MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET
  • 4.3 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY AND TYPE
    • FIGURE 16 ANTIBACTERIAL SUSCEPTIBILITY TESTING SEGMENT TO DOMINATE NORTH AMERICAN MARKET
  • 4.4 GEOGRAPHIC SNAPSHOT: KEY GROWTH OPPORTUNITIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
    • FIGURE 17 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of infectious diseases coupled with epidemic and pandemic events
      • 5.2.1.2 Increasing funding, research grants, and public-private investments
      • 5.2.1.3 Technological advancements
      • 5.2.1.4 Growing government initiatives to detect and control antimicrobial-resistant species
      • 5.2.1.5 Emergence of multidrug resistance due to drug abuse
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of automated ID/AST systems
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Complex regulatory frameworks
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 OVERVIEW
    • TABLE 2 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.2 THREAT OF NEW ENTRANTS
    • 5.3.3 THREAT OF SUBSTITUTES
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 BARGAINING POWER OF BUYERS
    • 5.3.6 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 NORTH AMERICA
      • 5.4.1.1 US
    • TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.4.1.2 Canada
    • TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.4.2 EUROPE
    • 5.4.3 ASIA PACIFIC
      • 5.4.3.1 Japan
    • TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY
      • 5.4.3.2 China
    • TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.4.3.3 India
  • 5.5 ECOSYSTEM ANALYSIS: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
    • FIGURE 19 ECOSYSTEM COVERAGE
  • 5.6 VALUE CHAIN ANALYSIS
    • 5.6.1 RESEARCH & DEVELOPMENT
    • 5.6.2 MANUFACTURING AND ASSEMBLY
    • 5.6.3 DISTRIBUTION, MARKETING AND SALES, AND POST-SALES SERVICES
    • FIGURE 20 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
    • 5.7.1 PROMINENT COMPANIES
    • 5.7.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • FIGURE 21 SUPPLY CHAIN ANALYSIS
  • 5.8 KEY CONFERENCES AND EVENTS IN 2023-2024
    • TABLE 8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS
    • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS
    • 5.9.2 BUYING CRITERIA
    • FIGURE 23 KEY BUYING CRITERIA FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS
    • TABLE 10 KEY BUYING CRITERIA FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS
  • 5.10 PATENT ANALYSIS
    • FIGURE 24 TOP 10 PATENT APPLICANTS
    • FIGURE 25 TOP 10 PATENT OWNERS

6 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 11 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 6.2 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS
    • TABLE 12 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 13 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.1 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE
    • TABLE 14 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.2.2 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY APPLICATION
    • TABLE 15 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 6.2.3 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY METHOD
    • TABLE 16 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • 6.2.4 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY END USER
    • TABLE 17 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 6.2.5 SUSCEPTIBILITY TESTING DISKS
      • 6.2.5.1 Significant adoption of disk diffusion tests in emerging countries to support segment growth
    • TABLE 18 SUSCEPTIBILITY TESTING DISKS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.5.2 Susceptibility testing disks market, by type
    • TABLE 19 SUSCEPTIBILITY TESTING DISKS MARKET, BY TYPE, 2020-2027 (USD MILLION)
      • 6.2.5.3 Susceptibility testing disks market, by application
    • TABLE 20 SUSCEPTIBILITY TESTING DISKS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
      • 6.2.5.4 Susceptibility testing disks market, by method
    • TABLE 21 SUSCEPTIBILITY TESTING DISKS MARKET, BY METHOD, 2020-2027 (USD MILLION)
      • 6.2.5.5 Susceptibility testing disks market, by end user
    • TABLE 22 SUSCEPTIBILITY TESTING DISKS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 6.2.6 MIC STRIPS
      • 6.2.6.1 Growing adoption of broad-spectrum MIC strips to support market growth
    • TABLE 23 MIC STRIPS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.6.2 MIC strips market, by type
    • TABLE 24 MIC STRIPS MARKET, BY TYPE, 2020-2027 (USD MILLION)
      • 6.2.6.3 MIC strips market, by application
    • TABLE 25 MIC STRIPS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
      • 6.2.6.4 MIC strips market, by method
    • TABLE 26 MIC STRIPS MARKET, BY METHOD, 2020-2027 (USD MILLION)
      • 6.2.6.5 MIC strips market, by end user
    • TABLE 27 MIC STRIPS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 6.2.7 SUSCEPTIBILITY TESTING PLATES
      • 6.2.7.1 Increasing adoption of automated/rapid AST systems hampering growth
    • TABLE 28 SUSCEPTIBILITY TESTING PLATES MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.7.2 Susceptibility testing plates market, by type
    • TABLE 29 SUSCEPTIBILITY TESTING PLATES MARKET, BY TYPE, 2020-2027 (USD MILLION)
      • 6.2.7.3 Susceptibility testing plates market, by application
    • TABLE 30 SUSCEPTIBILITY TESTING PLATES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
      • 6.2.7.4 Susceptibility testing plates market, by method
    • TABLE 31 SUSCEPTIBILITY TESTING PLATES MARKET, BY METHOD, 2020-2027 (USD MILLION)
      • 6.2.7.5 Susceptibility testing plates market, by end user
    • TABLE 32 SUSCEPTIBILITY TESTING PLATES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 6.3 AUTOMATED LABORATORY INSTRUMENTS
    • 6.3.1 ONGOING TREND OF LABORATORY AUTOMATION AMONG CLINICAL LABORATORIES TO FUEL GROWTH
    • TABLE 33 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.2 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY TYPE
    • TABLE 34 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.3.3 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY APPLICATION
    • TABLE 35 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 6.3.4 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY METHOD
    • TABLE 36 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • 6.3.5 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY END USER
    • TABLE 37 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 6.4 CULTURE AND GROWTH MEDIA
    • 6.4.1 HIGH UTILIZATION OF DISK DIFFUSION AND BROTH DILUTION METHODS TO DRIVE GROWTH
    • TABLE 38 CULTURE AND GROWTH MEDIA MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.4.2 CULTURE AND GROWTH MEDIA MARKET, BY TYPE
    • TABLE 39 CULTURE AND GROWTH MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.4.3 CULTURE AND GROWTH MEDIA MARKET, BY APPLICATION
    • TABLE 40 CULTURE AND GROWTH MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 6.4.4 CULTURE AND GROWTH MEDIA MARKET, BY METHOD
    • TABLE 41 CULTURE AND GROWTH MEDIA MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • 6.4.5 CULTURE AND GROWTH MEDIA MARKET, BY END USER
    • TABLE 42 CULTURE AND GROWTH MEDIA MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 6.5 CONSUMABLES
    • 6.5.1 INCREASING NUMBER OF SUSCEPTIBILITY TESTS PERFORMED AT HOSPITALS TO SUPPORT GROWTH
    • TABLE 43 CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.5.2 CONSUMABLES MARKET, BY TYPE
    • TABLE 44 CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.5.3 CONSUMABLES MARKET, BY APPLICATION
    • TABLE 45 CONSUMABLES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 6.5.4 CONSUMABLES MARKET, BY METHOD
    • TABLE 46 CONSUMABLES MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • 6.5.5 CONSUMABLES MARKET, BY END USER
    • TABLE 47 CONSUMABLES MARKET, BY END USER, 2020-2027 (USD MILLION)

7 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 48 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 7.2 ANTIBACTERIAL SUSCEPTIBILITY TESTING
    • 7.2.1 EMERGENCE OF MULTIDRUG-RESISTANCE TO INCREASE ADOPTION OF ANTIBACTERIAL SUSCEPTIBILITY TESTING PRODUCTS
    • TABLE 49 ANTIBACTERIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 ANTIFUNGAL SUSCEPTIBILITY TESTING
    • 7.3.1 INCREASING INFECTIONS OF CANDIDA AND ASPERGILLUS SPECIES TO DRIVE GROWTH
    • TABLE 50 NUMBER OF HOSPITALIZATIONS AND DIRECT MEDICAL COSTS ASSOCIATED WITH FUNGAL DISEASES IN US FOR FY 2019
    • TABLE 51 ANTIFUNGAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.4 ANTIPARASITIC SUSCEPTIBILITY TESTING
    • 7.4.1 RISING INITIATIVES TO CREATE AWARENESS ABOUT PARASITIC INFECTIONS TO DRIVE GROWTH
    • TABLE 52 ANTIPARASITIC SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.5 OTHER SUSCEPTIBILITY TESTING
    • TABLE 53 OTHER SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)

8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 54 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 8.2 CLINICAL DIAGNOSTICS
    • 8.2.1 TECHNOLOGICAL ADVANCEMENTS AND INCREASING NUMBER OF SUSCEPTIBILITY TESTS PERFORMED TO DRIVE GROWTH
    • TABLE 55 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 DRUG DISCOVERY AND DEVELOPMENT
    • 8.3.1 RISING ADOPTION OF RAPID AST SOLUTIONS BY BIOPHARMACEUTICAL COMPANIES TO DRIVE SEGMENT GROWTH
    • TABLE 56 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020-2027 (USD MILLION)
  • 8.4 EPIDEMIOLOGY
    • 8.4.1 OUTBREAK OF PANDEMICS AND EPIDEMICS TO DRIVE DEMAND FOR AST PRODUCTS
    • TABLE 57 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR EPIDEMIOLOGY, BY REGION, 2020-2027 (USD MILLION)
  • 8.5 OTHER APPLICATIONS
    • TABLE 58 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)

9 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD

  • 9.1 INTRODUCTION
    • TABLE 59 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2020-2027 (USD MILLION)
  • 9.2 AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING
    • 9.2.1 TECHNOLOGICAL ADVANCEMENTS AND FAVORABLE PRODUCT PIPELINE TO DRIVE GROWTH
    • TABLE 60 AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 DISK DIFFUSION
    • 9.3.1 RISING INCIDENCE OF URINARY TRACT INFECTIONS TO DRIVE GROWTH
    • TABLE 61 DISK DIFFUSION-BASED ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.4 AGAR DILUTION
    • 9.4.1 AGAR DILUTION HELPS EXPLORE DRUG COMBINATIONS FOR COMBINED ANTIBIOTIC THERAPY
    • TABLE 62 AGAR DILUTION-BASED ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.5 ETEST
    • 9.5.1 UNCERTAINTIES IN RESULT INTERPRETATION AFFECTING MARKET GROWTH
    • TABLE 63 ETEST-BASED ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.6 GENOTYPIC METHODS
    • 9.6.1 ONGOING CLINICAL TRIALS AND UPCOMING PRODUCT LAUNCHES SUPPORT GROWTH
    • TABLE 64 GENOTYPIC METHODS-BASED ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)

10 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 65 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.2 HOSPITALS AND DIAGNOSTIC CENTERS
    • 10.2.1 HIGH PREVALENCE OF INFECTIOUS DISEASES AND RISING ADOPTION OF RAPID AST SOLUTIONS TO DRIVE GROWTH
    • TABLE 66 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2020-2027 (USD MILLION)
  • 10.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 10.3.1 INCREASING NUMBER OF BIOPHARMACEUTICAL COMPANIES TO SUPPORT SEGMENT GROWTH
    • TABLE 67 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2027 (USD MILLION)
  • 10.4 RESEARCH AND ACADEMIC INSTITUTES
    • 10.4.1 GROWING RESEARCH GRANTS AND FUNDING TO ACCELERATE MARKET GROWTH
    • TABLE 68 FUNDING BY DEPARTMENT OF HEALTH AND SOCIAL CARE (UK) FOR ANTIMICROBIAL RESISTANCE STUDIES, 2020
    • TABLE 69 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2020-2027 (USD MILLION)
  • 10.5 CONTRACT RESEARCH ORGANIZATIONS
    • 10.5.1 CLINICAL TRIAL GLOBALIZATION AND GROWING NUMBER OF CROS IN EMERGING ECONOMIES TO DRIVE GROWTH
    • TABLE 70 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020-2027 (USD MILLION)

11 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 71 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 26 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
    • TABLE 72 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 73 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 74 NORTH AMERICA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 75 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 76 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 77 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 78 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 US to dominate North American market during forecast period
    • TABLE 79 US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 80 US: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Favorable government initiatives to drive growth during forecast period
    • TABLE 81 CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 82 CANADA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 11.3 EUROPE
    • TABLE 83 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 84 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 85 EUROPE: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 88 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 89 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Germany to dominate European market during forecast period
    • TABLE 90 GERMANY: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 91 GERMANY: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.2 FRANCE
      • 11.3.2.1 Supportive government policies and easy access to healthcare services to fuel growth
    • TABLE 92 FRANCE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 93 FRANCE: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Significant prevalence of infectious diseases coupled with increasing awareness of AST products to drive market growth
    • TABLE 94 UK: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 95 UK: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Increasing R&D investments by pharmaceutical companies to propel demand for AST products
    • TABLE 96 ITALY: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 97 ITALY: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Rising geriatric population to drive market growth
    • TABLE 98 SPAIN: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 99 SPAIN: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 100 REST OF EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 101 REST OF EUROPE: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 27 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
    • TABLE 102 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Growing geriatric population to drive market
    • TABLE 109 JAPAN: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 110 JAPAN: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Favorable government regulations and heavy burden of infectious diseases to drive market growth
    • TABLE 111 INCIDENCE OF INFECTIOUS DISEASES IN CHINA, 2020
    • TABLE 112 CHINA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 113 CHINA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Growing initiatives for clinical diagnosis by government and major players to drive market growth
    • TABLE 114 INDIA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 115 INDIA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.4 AUSTRALIA
      • 11.4.4.1 Increasing government funding for research activities to drive market growth
    • TABLE 116 AUSTRALIA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 117 AUSTRALIA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Requirement of rapid AMR detection to drive growth
    • TABLE 118 SOUTH KOREA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 119 SOUTH KOREA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.6 REST OF ASIA PACIFIC
    • TABLE 120 REST OF ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 121 REST OF ASIA PACIFIC: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 11.5 LATIN AMERICA
    • TABLE 122 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 123 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 124 LATIN AMERICA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 127 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 128 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.5.1 BRAZIL
      • 11.5.1.1 Established presence of major AST product manufacturers to drive growth
    • TABLE 129 BRAZIL: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 130 BRAZIL: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.5.2 MEXICO
      • 11.5.2.1 Growing economic development to drive market growth
    • TABLE 131 MEXICO: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 132 MEXICO: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 11.5.3 REST OF LATIN AMERICA
    • TABLE 133 REST OF LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 134 REST OF LATIN AMERICA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 GROWING INCIDENCE OF INFECTIOUS DISEASES AND LARGE PATIENT POOL TO DRIVE MARKET GROWTH
    • TABLE 135 MIDDLE EAST & AFRICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 136 MIDDLE EAST & AFRICA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 137 MIDDLE EAST & AFRICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 138 MIDDLE EAST & AFRICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 139 MIDDLE EAST & AFRICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 140 MIDDLE EAST & AFRICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN
    • TABLE 141 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
  • 12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
  • 12.4 MARKET SHARE ANALYSIS (2021)
    • FIGURE 29 BIOMERIEUX SA HELD LEADING POSITION IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2021
  • 12.5 COMPANY EVALUATION MATRIX FOR 25 MAJOR PLAYERS (2021)
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 30 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2021
  • 12.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2021)
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • FIGURE 31 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2021
  • 12.7 COMPETITIVE BENCHMARKING
    • TABLE 142 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
    • TABLE 143 APPLICATION FOOTPRINT ANALYSIS OF TOP PLAYERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
    • TABLE 144 REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES
    • TABLE 145 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2020-JANUARY 2023
    • 12.8.2 DEALS
    • TABLE 146 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DEALS, JANUARY 2020-JANUARY 2023

13 COMPANY PROFILES

(Business overview, Products offered, Recent Developments, MNM view)*

  • 13.1 KEY PLAYERS
    • 13.1.1 BIOMERIEUX SA
    • TABLE 147 COMPANY OVERVIEW: BIOMERIEUX SA
    • FIGURE 32 BIOMERIEUX SA: COMPANY SNAPSHOT
    • 13.1.2 BECTON, DICKINSON AND COMPANY
    • TABLE 148 COMPANY OVERVIEW: BECTON, DICKINSON AND COMPANY
    • FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
    • 13.1.3 THERMO FISHER SCIENTIFIC
    • TABLE 149 COMPANY OVERVIEW: THERMO FISHER SCIENTIFIC
    • FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
    • 13.1.4 DANAHER CORPORATION
    • TABLE 150 COMPANY OVERVIEW: DANAHER CORPORATION
    • FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT
    • 13.1.5 BIO-RAD LABORATORIES, INC.
    • TABLE 151 COMPANY OVERVIEW: BIO-RAD LABORATORIES, INC.
    • FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
    • 13.1.6 BRUKER
    • TABLE 152 COMPANY OVERVIEW: BRUKER
    • FIGURE 37 BRUKER: COMPANY SNAPSHOT
    • 13.1.7 ROCHE DIAGNOSTICS
    • TABLE 153 COMPANY OVERVIEW: ROCHE DIAGNOSTICS
    • FIGURE 38 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
    • 13.1.8 MERCK KGAA
    • TABLE 154 COMPANY OVERVIEW: MERCK KGAA
    • FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT
    • 13.1.9 ACCELERATE DIAGNOSTICS, INC.
    • TABLE 155 COMPANY OVERVIEW: ACCELERATE DIAGNOSTICS, INC.
    • FIGURE 40 ACCELERATE DIAGNOSTICS, INC.: COMPANY SNAPSHOT
    • 13.1.10 HIMEDIA LABORATORIES
    • TABLE 156 COMPANY OVERVIEW: HIMEDIA LABORATORIES
    • 13.1.11 LIOFILCHEM S.R.L.
    • TABLE 157 COMPANY OVERVIEW: LIOFILCHEM S.R.L.
    • 13.1.12 ALIFAX S.R.L.
    • TABLE 158 COMPANY OVERVIEW: ALIFAX S.R.L.
    • 13.1.13 CREATIVE DIAGNOSTICS
    • TABLE 159 COMPANY OVERVIEW: CREATIVE DIAGNOSTICS
    • 13.1.14 SYNBIOSIS
    • TABLE 160 COMPANY OVERVIEW: SYNBIOSIS
    • 13.1.15 BIOANALYSE
    • TABLE 161 COMPANY OVERVIEW: BIOANALYSE
  • 13.2 OTHER COMPANIES
    • 13.2.1 ZHUHAI DL BIOTECH CO., LTD.
    • 13.2.2 ELITECH GROUP
    • 13.2.3 MAST GROUP LTD.
    • 13.2.4 CONDALAB
    • 13.2.5 GENEFLUIDICS, INC.
    • 13.2.6 BIOTRON LTD.
    • 13.2.7 INVIVOGEN
    • 13.2.8 MP BIOMEDICALS
    • 13.2.9 QUANTAMATRIX INC.
    • 13.2.10 PML MICROBIOLOGICALS

Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS